MRGPRG (mrgrg_human)
FAMILY
Class A (Rhodopsin) Orphan receptors Class A orphans MRGPRG
GENE
MRGPRG (GPR169, MRGG)
ORGANISM
Human (Homo sapiens)
ALT. NAMES
Mas-related G-protein coupled receptor member G, G-protein coupled receptor 169
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
F
|
G
|
L
|
F
|
G
|
L
|
W
|
R
|
T
|
10 |
TM1 | |||||||||
F
|
D
|
S
|
V
|
V
|
F
|
Y
|
L
|
T
|
L
|
20 |
I
|
V
|
G
|
L
|
G
|
G
|
P
|
V
|
G
|
N
|
30 |
G
|
L
|
V
|
L
|
W
|
N
|
L
|
G
|
F
|
R
|
40 |
ICL1 | TM2 | ||||||||
I
|
K
|
K
|
G
|
P
|
F
|
S
|
I
|
Y
|
L
|
50 |
L
|
H
|
L
|
A
|
A
|
A
|
D
|
F
|
L
|
F
|
60 |
L
|
S
|
C
|
R
|
V
|
G
|
F
|
S
|
V
|
A
|
70 |
ECL1 | TM3 | ||||||||
Q
|
A
|
A
|
L
|
G
|
A
|
Q
|
D
|
T
|
L
|
80 |
Y
|
F
|
V
|
L
|
T
|
F
|
L
|
W
|
F
|
A
|
90 |
V
|
G
|
L
|
W
|
L
|
L
|
A
|
A
|
F
|
S
|
100 |
V
|
E
|
R
|
C
|
L
|
S
|
D
|
L
|
F
|
P
|
110 |
ICL2 | TM4 | ||||||||
A
|
C
|
Y
|
Q
|
G
|
C
|
R
|
P
|
R
|
H
|
120 |
A
|
S
|
A
|
V
|
L
|
C
|
A
|
L
|
V
|
W
|
130 |
T
|
P
|
T
|
L
|
P
|
A
|
V
|
P
|
L
|
P
|
140 |
ECL2 | |||||||||
A
|
N
|
A
|
C
|
G
|
L
|
L
|
R
|
N
|
S
|
150 |
TM5 | |||||||||
A
|
C
|
P
|
L
|
V
|
C
|
P
|
R
|
Y
|
H
|
160 |
V
|
A
|
S
|
V
|
T
|
W
|
F
|
L
|
V
|
L
|
170 |
A
|
R
|
V
|
A
|
W
|
T
|
A
|
G
|
V
|
V
|
180 |
L
|
F
|
V
|
W
|
V
|
T
|
C
|
C
|
S
|
T
|
190 |
ICL3 | TM6 | ||||||||
R
|
P
|
R
|
P
|
R
|
L
|
Y
|
G
|
I
|
V
|
200 |
L
|
G
|
A
|
L
|
L
|
L
|
L
|
F
|
F
|
C
|
210 |
G
|
L
|
P
|
S
|
V
|
F
|
Y
|
W
|
S
|
L
|
220 |
ECL3 | |||||||||
Q
|
P
|
L
|
L
|
N
|
F
|
L
|
L
|
P
|
V
|
230 |
TM7 | |||||||||
F
|
S
|
P
|
L
|
A
|
T
|
L
|
L
|
A
|
C
|
240 |
V
|
N
|
S
|
S
|
S
|
K
|
P
|
L
|
I
|
Y
|
250 |
H8 | |||||||||
S
|
G
|
L
|
G
|
R
|
Q
|
P
|
G
|
K
|
R
|
260 |
E
|
P
|
L
|
R
|
S
|
V
|
L
|
R
|
R
|
A
|
270 |
C-term | |||||||||
L
|
G
|
E
|
G
|
A
|
E
|
L
|
G
|
A
|
R
|
280 |
G
|
Q
|
S
|
L
|
P
|
M
|
G
|
L
|
L
|
LINKS
DIAGRAMS
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
No physiological ligands available
STRUCTURE MODELS
STRUCTURES
No structures available